Schippinger, Walter <br/><br/>
Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.  [electronic resource] 

 -  Oncology  2006 
 - 290-3 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0030-2414 
<br/><br/><label>Standard No.: </label>10.1159/000094890  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Colony-Stimulating Factors--therapeutic use<br/>Docetaxel<br/>Epirubicin--administration & dosage<br/>Female<br/>Fever--epidemiology<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Lenograstim<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Paclitaxel--administration & dosage<br/>Polyethylene Glycols<br/>Recombinant Proteins--therapeutic use<br/>Taxoids--administration & dosage